Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
History
Business
Sports
News
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts126/v4/ea/4c/ed/ea4ced20-6604-4de1-75e4-17d757d6e0d2/mza_8360496711220127438.jpg/600x600bb.jpg
Prescription for Better Access
Mark Hansan and Dr. Scott Howell
34 episodes
2 weeks ago
The FDA’s Accelerated Approval Program (AAP) aims to bring promising, potentially life-saving medicines to patients sooner by allowing approvals based on surrogate endpoints while requiring timely ...
Show more...
Medicine
Technology,
Health & Fitness,
Science,
Life Sciences
RSS
All content for Prescription for Better Access is the property of Mark Hansan and Dr. Scott Howell and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
The FDA’s Accelerated Approval Program (AAP) aims to bring promising, potentially life-saving medicines to patients sooner by allowing approvals based on surrogate endpoints while requiring timely ...
Show more...
Medicine
Technology,
Health & Fitness,
Science,
Life Sciences
Episodes (20/34)
Prescription for Better Access
Understanding the Impact of the Accelerated Approvals Program
1 month ago

Prescription for Better Access
Charting a Path Forward for More Patient-Centered Value Assessment Methods
2 months ago

Prescription for Better Access
IRA, Part D Redesign & the Future of Drug Access: A Conversation with Jon Blum, Former CMS Principal Deputy Administrator and COO
3 months ago

Prescription for Better Access
The Future of Access, a Live Podcast Recording from the ACCESS US 2025 Conference
5 months ago

Prescription for Better Access
The Domino Effect: 2025 Trends in Specialty Drug Benefits Report
7 months ago
50 minutes

Prescription for Better Access
Inside the Cost Curve: An Interview with Brian Reid
8 months ago
45 minutes

Prescription for Better Access
Value in Prescription Drugs – What Does It Really Mean?
9 months ago
51 minutes

Prescription for Better Access
An interview with Sarah Emond, MPP, President and CEO, Institute for Clinical Economic Review (ICER)
10 months ago
43 minutes

Prescription for Better Access
2025 Outlook with Stacie Dusetzina, Ph.D., Vanderbilt University
1 year ago
47 minutes

Prescription for Better Access
Cell and Gene Therapy Access Challenges
1 year ago
53 minutes

Prescription for Better Access
Global vs. US Drug Pricing and Market Access
1 year ago
54 minutes

Prescription for Better Access
22. Honoring the Work of Healthcare Advocates
1 year ago
44 minutes

Prescription for Better Access
Evolution of PBM's
1 year ago
45 minutes

Prescription for Better Access
How Access Challenges Impact the Drug Development Pipeline
1 year ago
49 minutes

Prescription for Better Access
Interviews from Asembia’s AXS24 Summit, Part 2
1 year ago
33 minutes

Prescription for Better Access
Interviews from Asembia's AXS24 Summit, Part 1 of 2
1 year ago
35 minutes

Prescription for Better Access
Understanding 340B Programs: An Interview with Antonio Ciaccia, CEO, 46brooklyn Research
1 year ago
46 minutes

Prescription for Better Access
Interview with Victor Bulto, President, US, Novartis
1 year ago
43 minutes

Prescription for Better Access
Biosimilar's Role in Improving Patient Access
1 year ago
42 minutes

Prescription for Better Access
2024 Policy Preview: An Interview with Dr. Mark McClellan
1 year ago
49 minutes

Prescription for Better Access
The FDA’s Accelerated Approval Program (AAP) aims to bring promising, potentially life-saving medicines to patients sooner by allowing approvals based on surrogate endpoints while requiring timely ...